Retraction Note: Lysyl oxidase is essential for hypoxia-induced metastasis (Nature, (2006), 440, 7088, (1222-1226), 10.1038/nature04695);Lysyl oxidase is essential for hypoxia-induced metastasis

Nature

Volumn 440, Issue 7088, 2006, Pages 1222-1226

  Erler, Janine T ^a   Bennewith, Kevin L ^a   Nicolau, Monica ^a   Dornhöfer, Nadja ^b   Kong, Christina ^a   Le, Quynh Thu ^a   Chi, Jen Tsan Ashley ^c   Jeffrey, Stefanie S ^a   Giaccia, Amato J ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESION; CELLS; DRUG PRODUCTS; ENZYME KINETICS; TUMORS;

METASTASIS; THERAPEUTIC TARGETS; TUMOUR PROGRESSION; TUMOUR SUPPRESSION;

ENZYMES;

HYPOXIA INDUCIBLE FACTOR 1; PROTEIN LYSINE 6 OXIDASE; SCATTER FACTOR;

ADHESION; CANCER; CELL ORGANELLE; HEALTH AND DISEASE; HEALTH CARE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER INVASION; CELL DEATH; CELL INTERACTION; CELL TYPE; CONTROLLED STUDY; DNA MICROARRAY; EXTRACELLULAR MATRIX; FEMALE; GROWTH INHIBITION; HEAD AND NECK TUMOR; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; MALIGNANT TRANSFORMATION; METASTASIS; METASTASIS POTENTIAL; MICROENVIRONMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; TARGET CELL; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

ANIMALIA;

EID: 33646365644     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/s41586-020-2112-4     Document Type: Erratum

References (29)

1. Cairns, R. A., Khokha, R. & Hill, R. P. Molecular mechanisms of tumor invasion and metastasis: An integrated view. Curr. Mol. Med. 3, 659-671 (2003).
2. Hockel, M. & Vaupel, P. Tumor hypoxia: Definitions and current clinical, biologic, and molecular aspects. J. Natl Cancer Inst. 93, 266-276 (2001).
3. Denko, N. C. et al. Investigating hypoxic tumor physiology through gene expression patterns. Oncogene 22, 5907-5914 (2003).
4. Kagan, H. M. & Li, W. Lysyl oxidase: Properties, specificity, and biological roles inside and outside of the cell. J. Cell. Biochem. 88, 660-672 (2003).
5. Kaneda, A. et al. Lysyl oxidase is a tumor suppressor gene inactivated by methylation and loss of heterozygosity in human gastric cancers. Cancer Res. 64, 6410-6415 (2004).
6. Csiszar, K. et al. Somatic mutations of the lysyl oxidase gene on chromosome 5q23.1 in colorectal tumors. Int. J. Cancer 97, 636-642 (2002).
7. Palamakumbura, A. H. et al. The propeptide domain of lysyl oxidase induces phenotypic reversion of ras-transformed cells. J. Biol. Chem. 279, 40593-40600 (2004).
8. Kirschmann, D. A. et al. A molecular role for lysyl oxidase in breast cancer invasion. Cancer Res. 62, 4478-4483 (2002).
9. Payne, S. L. et al. Lysyl oxidase regulates breast cancer cell migration and adhesion through a hydrogen peroxide-mediated mechanism. Cancer Res. 65, 11429-11436 (2005).
10. Chang, H. Y. et al. Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. Proc. Natl Acad. Sci. USA 102, 3738-3743 (2005).
11. Chen, Y. et al. Identification of hypoxia-regulated proteins in head and neck cancer by proteomic and tissue array profiling. Cancer Res. 64, 7302-7310 (2004).
12. Chi, J. T. et al. Gene expression programs in response to hypoxia: Cell type specificity and prognostic significance in human cancers. PLoS Med. 3, e47 (2006).
13. Palmieri, D. et al. Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in hormone receptor-negative breast cancer. J. Natl Cancer Inst. 97, 632-642 (2005).
14. Csiszar, K. Lysyl oxidases: a novel multifunctional amine oxidase family. Prog. Nucleic Acid Res. Mol. Biol. 70, 1-32 (2001).
15. Cen, D., Brayton, D., Shahandeh, B., Meyskens, F. L. Jr & Farmer, P. J. Disulfiram facilitates intracellular Cu uptake and induces apoptosis in human melanoma cells. J. Med. Chem. 47, 6914-6920 (2004).
16. Janda, E. et al. Ras and TGFβ cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways. J. Cell Biol. 156, 299-313 (2002).
17. Friedl, P. & Wolf, K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nature Rev. Cancer 3, 362-374 (2003).
18. Krishnamachary, B. et al. Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. Cancer Res. 63, 1138-1143 (2003).
19. Fogelgren, B. et al. Cellular fibronectin binds to lysyl oxidase with high affinity and is critical for its proteolytic activation. J. Biol. Chem. 280, 24690-24697 (2005).
20. Yoon, S. O., Shin, S. & Mercurio, A. M. Hypoxia stimulates carcinoma invasion by stabilizing microtubules and promoting the Rab11 trafficking of the α6β4 integrin. Cancer Res. 65, 2761-2769 (2005).
21. Leufgen, H. et al. Collagenase expression and activity is modulated by the interaction of collagen types, hypoxia, and nutrition in human lung cells. J. Cell. Physiol. 204, 146-154 (2005).
22. Kaplan, R. N. et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438, 820-827 (2005).
23. Wang, W. et al. Gene expression analysis on small numbers of invasive cells collected by chemotaxis from primary mammary tumors of the mouse. BMC Biotechnol. 3, 13 (2003).
24. Erler, J. T. et al. Hypoxia-mediated down-regulation of Bid and Bax in tumors occurs via hypoxia-inducible factor 1-dependent and -independent mechanisms and contributes to drug resistance. Mol. Cell. Biol. 24, 2875-2889 (2004).
25. Moody, S. E. et al. The transcriptional repressor Snail promotes mammary tumor recurrence. Cancer Cell 8, 197-209 (2005).
26. Tazuke, S. I. et al. Hypoxia stimulates insulin-like growth factor binding protein 1 (IGFBP-1) gene expression in HepG2 cells: a possible model for IGFBP-1 expression in fetal hypoxia. Proc. Natl Acad. Sci. USA 95, 10188-10193 (1998).
27. Spicher, A. et al. Highly conserved RNA sequences that are sensors of environmental stress. Mol. Cell. Biol. 18, 7371-7382 (1998).
28. Bedogni, B. et al. Topical treatment with inhibitors of the phosphatidylinositol 3′-kinase/Akt and Raf/mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathways reduces melanoma development in severe combined immunodeficient mice. Cancer Res. 64, 2552-2560 (2004).
29. Gilad, G. M. & Gilad, V. H. Beta-aminopropionitrile treatment can accelerate recovery of mice after spinal cord injury. Eur. J. Pharmacol. 430, 69-72 (2001).